Journal articlesAdvazorb® foam range: providing clinical performance and cost-effectiveness

Advazorb® foam range: providing clinical performance and cost-effectiveness

01/09/11 | Acute wounds, Products, Service delivery, Wellbeing and concordance | Leanne Cook

The use of advanced wound dressings currently presents a costly burden to the NHS. Subsequently, clinicians need to ensure that such dressings are used appropriately and are clinically effective. This article discusses the merits of foam dressings within wound care and describes three clinical case reports using Advazorb® foam dressings (Advancis Medical) in the treatment of acute/chronic wounds. These foam dressings include a range of wound care solutions, which have been found to be clinically effective while potentially providing financial benefits without compromising quality of care.